| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.058 | 0.07 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.1 | 0.07 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.098 | 0.07 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.07 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.07 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |